cbdMD Stock Forecast for 2023 - 2025 - 2030

Updated on 04/26/2024

Stock Rating
0
Price Target
$2.00
Consensus
Outperform
Upside
122.22%
Analysts
1
Stock Rating
0
Upside
122.22%
Analysts
1
Price Target
$2.00

cbdMD Stock Forecast and Price Target

In recent months, notable analysts have provided yearlong price targets for cbdMD, with the average target coming in at $2.00. If it were to be achieved, this would result in a potential upside of approximately 122.22 percent from the most recent closing price in April, 2024. The high end is $2.00, and the low is $2.00. If you're interested in YCBD stock, looking at its competitors might also be a good idea.

$2.00

122.22% Upside

Outperform
Outperform

cbdMD Fair Value Forecast for 2023 - 2025 - 2030

In the last two years, Price for cbdMD has grown by 100.00%, going from $0.00 to $0.00. In the coming year, analysts are expecting an increase in Fair Value, predicting it will reach $0.94 – an increase of 100.00%. Over the next seven years, experts anticipate that Fair Value growth for cbdMD will be 100.00%.

2024 Fair Value Forecast
$0.94
2025 Fair Value Forecast
$1.05
2026 Fair Value Forecast
$1.17
2027 Fair Value Forecast
$1.30
2028 Fair Value Forecast
$1.44
2029 Fair Value Forecast
$1.60
2030 Fair Value Forecast
$1.78
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ACB Stock Forecast Aurora Cannabis Outperform 6
C$9.16 Buy/Sell C$1.06 -12.66%
WEED Stock Forecast Canopy Growth Hold 7
C$11.86 Buy/Sell C$0.94 -49.41%
CWEB Stock Forecast Charlotte's Web Holdings Outperform 0
C$0.27 Buy/Sell C$0.65 103.70%
CVSI Stock Forecast CV Sciences - 0
$0.04 Buy/Sell $0.05 -100.00%
VFRM Stock Forecast Veritas Farms - 0
$0.02 Buy/Sell $0.00 -100.00%

cbdMD Revenue Forecast for 2023 - 2025 - 2030

In the last three years, cbdMD's Revenue has fallen from $41.88M to $24.16M – a 42.31% decrease. In the coming year, analysts are expecting an increase in Revenue, predicting it will reach $27.49M – an increase of 13.78%. Over the next seven years, experts anticipate that Revenue growth for cbdMD will be 33.90%.

2024 Rev Forecast
$0.03B
2025 Rev Forecast
$0.03B
2026 Rev Forecast
$0.03B
2027 Rev Forecast
$0.03B
2028 Rev Forecast
$0.03B
2029 Rev Forecast
$0.03B
2030 Rev Forecast
$0.03B

cbdMD Dividend per Share Forecast for 2023 - 2025 - 2030

cbdMD Free Cash Flow Forecast for 2023 - 2025 - 2030

cbdMD EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, cbdMD's EBITDA has decreased from $-16.37M to $-7.47M – a 54.37% drop. For next year, the 0 analysts predict EBITDA of $-10.34M, which would mean an increase of 38.47%. Over the next seven years, the pros' prediction is EBITDAof $-14.03M, which would mean a seven-year growth forecast of 87.75%.

2024 EBITDA Forecast
$-10343460.00
2025 EBITDA Forecast
$-13777833.50
2026 EBITDA Forecast
$-16281725.11
2027 EBITDA Forecast
$-12586316.23
2028 EBITDA Forecast
$-12126915.69
2029 EBITDA Forecast
$-12845233.33
2030 EBITDA Forecast
$-14025282.10

cbdMD EBIT Forecast for 2023 - 2025 - 2030

cbdMD's EBIT has decreased by 45.76% In the last three years, from $-17.09M to $-9.27M. In the following year, the 1 analysts surveyed believe that cbdMD's EBIT will decrease by 22.98%, reaching $-7.14M. According to professionals, by 2030, cbdMD's EBIT will have decreased by 23.99%, falling down to $-7.05M.

2024 EBIT Forecast
$-7140000.00
2025 EBIT Forecast
$-4350000.00
2026 EBIT Forecast
$-6970150.00
2027 EBIT Forecast
$-8280073.52
2028 EBIT Forecast
$-8576224.15
2029 EBIT Forecast
$-6950743.80
2030 EBIT Forecast
$-7046200.68

cbdMD EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last two years, EPS for cbdMD has grown by 100.00%, going from $-16.89 to $0.00. In the coming year, analysts are expecting an increase in EPS, predicting it will reach $-2.10 – an increase of 100.00%. Over the next seven years, experts anticipate that EPS growth for cbdMD will be 100.00%.

2024 EPS Forecast
$-2.10
2025 EPS Forecast
$-0.87
2026 EPS Forecast
$-1.28
2027 EPS Forecast
$-1.32
2028 EPS Forecast
$-1.79
2029 EPS Forecast
$-1.42
2030 EPS Forecast
$-1.41